Open AccessLaboratory-based surveillance of Shigella spp. from human clinical cases in Colombia, 1997-2018
Author(s) -
Ernesto Suárez Rodríguez,
Adriana Bautista,
Lucy Angeline Montaño,
María Victoria Ovalle,
Francia Patricia Correa
Publication year - 2021
Publication title -
biomédica/biomedica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.26
H-Index - 28
eISSN - 2590-7379
pISSN - 0120-4157
DOI - 10.7705/biomedica.5113
Subject(s) - shigellosis , ampicillin , shigella sonnei , microbiology and biotechnology , cefotaxime , shigella , ciprofloxacin , antibiotic resistance , shigella flexneri , sulfamethoxazole , trimethoprim , medicine , ceftazidime , biology , antibiotics , salmonella , biochemistry , genetics , escherichia coli , pseudomonas aeruginosa , bacteria , gene
Shigellosis is endemic in low-and middle-income countries, causing approximately 125 million episodes of diarrhea and leading to approximately 160 .000 deaths annually one-third of which is associated with children.